T1: 16.7%, T2: 28.6%, T3: 47.6%, T4: 4.8% (of the 42 patients with known stages) Local resection: 38%, radiation: 21%, cystectomy: 40% Local recurrence: 3, death: 6 (of the 17 T3 cases)
SEER, National Cancer Institute Surveillance, Epidemiology, and End Results; UC, urethral cancer; SCC, squamous cell carcinoma.